Biotie Therapies (BITI) announced changes in its management team. The company has appointed Antero Kallio, M.D., as the new CEO and Kristian Rantala as CFO effective July 1. Also, Timo Veromaa, President and CEO; David Cook, CFO and Stephen Bandak, CMO are leaving the Company. BITI was acquired by Acorda Therapeutics (ACOR) earlier in the year.